September 4, 2013
  • Continued Use of Incretins Recommended, Despite Cancer Questions

    Not enough evidence exists on a possible link between incretin mimetics and pre-cancerous changes in the pancreas to recommend against use of the diabetes drugs, according to a new consensus statement from the American Association of Clinical Endocrinologists. Some caution is recommended, however. Find out what the statement says about possible other reasons for increased cancer risk. 

  • Therapeutic Drug Substitutions Save Medicare Far More Than Generic Equivalents

    Swapping out a drug that has a similar treatment effect could double or even triple annual Medicare Part D savings compared to just substituting a generic equivalent. Study authors from UCLA call for more research on the issue, recognizing that the trade-off could be a hard sell for physicians and patients.

  • Who Should Not Receive Specific—or Any—Flu Vaccines

    Public health officials have been quite clear on who should receive influenza vaccinations—almost anyone older than 6 months of age. What is less obvious to pharmacists and others, however, is who should not be vaccinated. That’s why the CDC issued a new update on the issue.

  • Treatment Nonexistent or Inadequate for Many
    Psoriasis Patients

    A surprisingly high percentage of psoriasis and psoriatic arthritis patients receive no treatment for their condition, even among those with moderate or severe disease. That’s according to a new survey that also found elevated rates of patient dissatisfaction on how psoriasis is managed. Here are the details.

U.S. Pharmacist Social Connect